Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

345 Views

150. HIV: Treatment: Friday, 12:15 - 1:30 p.m.

Poster Session: HIV: Treatment

(1607) Clinical Outcomes at Month 6 after Initiation of Cabotegravir and Rilpivirine Long-Acting (CAB + RPV LA) in an Observational Real-World Study (BEYOND)

Friday, October 13, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Michael Sension, MD (he/him/his)

Medical Director
CAN Community Health
Fort Lauderdale, Florida, United States

AD

Alexandra Dretler, MD

Physician
Infectious Disease Specialists of Atlanta
Decatur, Georgia, United States
SS

Stefan Schneider, MD

Long Beach Education and Research Consultants, Long Beach, CA, USA
Long Beach, California, United States
CS

Catherine K. Schubert, PharmD

Medical Science Liaison
ViiV Healthcare
RTP, North Carolina, United States
DM

Deanna Merrill, PharmD, MBA, AAHIVP

Medical Affairs Scientific Director, Research
ViiV Healthcare
Research Triangle Park, North Carolina, United States
DR

David Richardson, BA

RTI Health Solutions
Research Triangle Park, North Carolina, United States
BS

Bintu Sherif, MS

RTI Health Solutions
Research Triangle Park, North Carolina, United States
LZ

Laurie Zografos, BS

RTI Health Solutions
Research Triangle Park, North Carolina, United States
Cindy Garris, MS (she/her/hers)

Senior Director, US Health Outcomes
ViiV Healthcare
Durham, NC, United States